Form 8-K - Current report:
SEC Accession No. 0001384101-21-000051
Filing Date
2021-03-22
Accepted
2021-03-22 09:21:32
Documents
14
Period of Report
2021-03-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K vcyt-20210319.htm   iXBRL 8-K 38233
  Complete submission text file 0001384101-21-000051.txt   187248

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcyt-20210319.xsd EX-101.SCH 2436
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcyt-20210319_cal.xml EX-101.CAL 722
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcyt-20210319_def.xml EX-101.DEF 1659
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcyt-20210319_lab.xml EX-101.LAB 25298
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcyt-20210319_pre.xml EX-101.PRE 13202
7 EXTRACTED XBRL INSTANCE DOCUMENT vcyt-20210319_htm.xml XML 12624
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 21760132
SIC: 8071 Services-Medical Laboratories